Nab-paclitaxel,Cyclophosphamide
ImmunityBio
[]
$ibrx immunitybio announces presentation at asco gi 2023 of fully enrolled trial in third-line and greater pancreatic cancer and update on fda type b meetings regarding paths to registration 